ERK-derived peptides and uses thereof
US10240133B2 · kind B2 · utility
0Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2017 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Apr 27, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An isolated peptide being no longer than 20 amino acids comprising a sequence at least 95% homologous to the sequence GQLNHILGILGX1PX2QED (SEQ ID NO: 4), wherein X1 and X2 are any amino acid, the peptide being capable of preventing extracellular signal-regulated kinase1/2 (ERK) translocation into the nucleus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.